research communications
Structure of the human histone chaperone FACT Spt16 N-terminal domain
aCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, Scotland
*Correspondence e-mail: d.huang@beatson.gla.ac.uk
The histone chaperone FACT plays an important role in facilitating nucleosome assembly and disassembly during transcription. FACT is a heterodimeric complex consisting of Spt16 and SSRP1. The N-terminal domain of Spt16 resembles an inactive aminopeptidase. How this domain contributes to the histone chaperone activity of FACT remains elusive. Here, the Saccharomyces cerevisiae and Schizosaccharomyces pombe Spt16 NTDs. Isothermal titration analyses show that human Spt16 NTD binds histones H3/H4 with low-micromolar affinity, suggesting that Spt16 NTD may contribute to histone binding in the FACT complex. Surface-residue conservation and electrostatic analysis reveal a conserved acidic patch that may be involved in histone binding.
of the N-terminal domain (NTD) of human Spt16 is reported at a resolution of 1.84 Å. The structure adopts an aminopeptidase-like fold similar to those of theKeywords: FACT; Spt16; histone chaperone; histones; pita-bread fold; aminopeptidase.
PDB reference: N-terminal domain of human Spt16, 5e5b
1. Introduction
Eukaryotes package their DNA into nucleosomes, which consist of four histone proteins, H2A, H2B, H3 and H4, that associate to form two H2A/H2B heterodimers and one H3/H4 heterotetramer. Two H2A/H2B heterodimers and one H3/H4 heterotetramer associate to form an octamer around which 147 bp of DNA are wrapped (Luger et al., 1997). Histone chaperones play important roles in directing histone deposition into DNA and histone disassembly from the nucleosome to facilitate DNA replication, transcription and DNA-damage response (Gurard-Levin et al., 2014).
Facilitating chromatin transcription (FACT) is a histone chaperone consisting of a heterocomplex of suppressor of Ty 16 (Spt16) and structure-specific recognition protein 1 (SSRP1). Early in vitro studies showed that FACT displaces the H2A/H2B dimer from the nucleosome template to facilitate RNA polymerase II-driven transcription and has the ability to deposit histones onto DNA (Orphanides et al., 1998, 1999). Subsequent studies showed that when FACT is incubated with H2AX and the nucleosome, it can catalyse the exchange of H2AX with H2A within the nucleosome (Heo et al., 2008) and compete against DNA for H2A/H2B binding but not the H3/H4 tetramer (Winkler et al., 2011). These studies support a model in which FACT functions as an H2A/H2B exchanger. A recent study has shown that yeast FACT can relax DNA–histone interactions without removing H2A/H2B and the loss of dimer is likely to be owing to reorganization of the destabilized nucleosome (Xin et al., 2009). Nonetheless, to destabilize the nucleosome, FACT is likely to disrupt DNA–histone interactions by binding directly to the histones. Indeed, early studies showed that FACT and both subunits of FACT can bind histones (Belotserkovskaya et al., 2003; Formosa et al., 2001). Moreover, affinity analyses showed that FACT interacts with the core domains and N-terminal tails of both histones H2A/H2B and H3/H4 through several synergistic binding events involving both Spt16 and SSRP1 (Winkler et al., 2011). How Spt16 and SSRP1 interact with histones remains elusive.
SSRP1 contains an N-terminal Spt16-binding domain followed by a middle domain (MD) and a C-terminal HMG domain. SSRP1 MD adopts two pleckstrin-homology (PH) folds and has been shown to bind histone H3/H4 (VanDemark et al., 2006; Zunder et al., 2012). Genetic analysis of yeast SSRP1 MD revealed that some mutations, including Q308K, can induce temperature sensitivity, hydroxyurea sensitivity and an Spt− phenotype, suggesting the importance of this domain in transcription and DNA replication, possibly through interactions with histones (VanDemark et al., 2006). The HMG domain has been shown to bind nucleosomal DNA and this interaction causes DNA bending, leading to minor-groove widening that may disrupt DNA–histone interactions (Masse et al., 2002; Kasai et al., 2005).
Spt16 consists of an NTD followed by an SSRP1 dimerization domain, MD and C-terminal domain. Spt16 MDs from Chaetomium thermophilum and Saccharomyces cerevisiae have been shown to interact with histone H3/H4, and C. thermophilum Spt16 MD also binds H2/H2B (Kemble et al., 2013; Hondele et al., 2013). The structure of Spt16 MD reveals two PH domains in tandem and it shares structural similarity with SSRP1 MD and RTT106; however, it has three additional α-helices located at the C-terminus that form a U-turn motif. This motif interacts with the H2A/H2B dimer via hydrophobic interactions with residues on the H2B α1 helix (Hondele et al., 2013). Interestingly, most of the Spt16 mutations that affect FACT activity are in Spt16 MD (Myers et al., 2011; Formosa et al., 2001). These mutations can be suppressed by destabilizing H2A/H2B dimer and H3/H4 tetramer interactions (Myers et al., 2011; McCullough et al., 2011; Hainer et al., 2012), suggesting that Spt16 MD is responsible for establishing important interactions with the nucleosome. The Spt16 C-terminal domain consists of highly intrinsically disordered acidic residues. Removal of these regions hampers the ability of FACT to bind nucleosomes and histones and to promote transcription (Belotserkovskaya et al., 2003; Myers et al., 2011). A recent structural study showed that the Spt16 and SSRP1 C-terminal flexible acidic residues contain a tyrosine or phenylalanine residue, respectively, that binds to a hydrophobic pocket in H2B (Kemble et al., 2015). This interaction overlaps with nucleosomal DNA–H2A/H2B interactions, suggesting that FACT might promote reorganization of the nucleosomes by competing with DNA for histone binding.
The function of Spt16 NTD remains unclear. Studies in yeast showed that deletion of this domain or mutations in specific conserved residues do not disrupt essential functions of yeast FACT. However, when combined with the yeast SSRP1 MD Q308K mutation that causes defects in DNA replication and transcription, the effect is lethal, suggesting that Spt16 NTD functionally overlaps with SSRP1 MD (O'Donnell et al., 2004; VanDemark et al., 2008). Furthermore, genetic analyses showed that Spt16 NTD might interact with the C-terminal extension of H2A (VanDemark et al., 2008). The structures of Spt16 NTD from S. cerevisiae and Schizosaccharomyces pombe (PDB entries 3bip and 3cb5 , respectively) reveal an aminopeptidase-like domain that resembles a `pita-bread' fold and which has lost its aminopeptidase activity (Stuwe et al., 2008; VanDemark et al., 2008). Studies on S. pombe Spt16 NTD showed that it forms a tight complex with histone H3/H4. Moreover, it binds H3 and H4 N-terminal tails with low-micromolar affinity (Stuwe et al., 2008). In contrast, no binding of histone N-terminal tails could be observed with S. cerevisiae Spt16 NTD (VanDemark et al., 2008). To further elucidate the role of Spt16 NTD in histone interactions, we determined the of human Spt16 NTD and examined its histone-binding ability.
2. Materials and methods
2.1. Macromolecule production
The gene for human Spt16 NTD (residues 1–510) was cloned into pGEX-4T-1 vector (Novagen) using standard PCR ligation techniques such that the protein is expressed with an N-terminal glutathione S-transferase (GST) tag followed by a TEV protease cleavage site. The resulting vector was transformed into Escherichia coli BL21 (DE3) Gold competent cells. The cells were grown at 310 K in LB to an OD600 of ∼0.7–0.8 and then induced with 0.2 mM isopropyl β-D-1-thiogalactopyranoside overnight at 293 K. The following day, the cells were harvested and resuspended in 50 mM Tris–HCl pH 7.6, 0.2 M NaCl, 1 mM DTT, 2.5 mM phenylmethylsulfonyl fluoride, 1 mg ml−1 lysozyme and then subjected to a freeze–thaw cycle. The cells were lysed by sonication and then centrifuged at 48 000g for 25 min at 277 K using a JA-25.50 rotor (Beckman Coulter) to remove cell debris. GST-Spt16 NTD was purified from the lysate by glutathione Sepharose The GST tag was released by incubation with TEV protease and subsequently removed with a glutathione Sepharose column. Cleaved Spt16 NTD was then purified by anion-exchange (Source Q, GE Life Sciences) in buffer consisting of 50 mM Tris–HCl pH 7.6, 1 mM DTT, 0–1 M NaCl and by (Superdex 75, GE Life Sciences) in buffer consisting of 25 mM Tris–HCl pH 7.6, 150 mM NaCl, 1 mM DTT. Fractions containing Spt16 NTD were pooled together and concentrated to about 13.3 mg ml−1. The protein was then cooled in liquid nitrogen and stored at 193 K. Gallus gallus histone octamer proteins (H2A, H2B, H3 and H4) were purified from chicken blood (Lambert et al., 1999) and separated into histones H2A/H2B and H3/H4 by cation-exchange (Source S, GE Life Sciences) using a 0–2 M KCl gradient in buffer consisting of 50 mM KH2PO4, 50 mM K2HPO4 pH 6.5, 1 mM DTT. Proteins were then frozen in liquid nitrogen and stored at 193 K.
2.2. Crystallization
Spt16 NTD (13.3 mg ml−1) was mixed with an equal volume of reservoir solution consisting of 0.1 M sodium acetate pH 5.0, 17%(w/v) PEG 3350, 0.1 M ammonium iodide using the hanging-drop vapour-diffusion method at 292 K. Crystals appeared after 1 d and were flash-cooled in 0.1 M sodium acetate pH 5.0, 17%(w/v) PEG 3350, 0.1 M ammonium iodide, 20%(w/v) glycerol (Table 1).
|
2.3. Data collection and processing
Diffraction data from human Spt16 NTD crystals were collected on beamline I02 at Diamond Light Source (DLS). Data obtained at 100 K were integrated, merged and scaled using the automated XDS (Kabsch, 2010; Winter, 2010) method applied at the beamline. Data-collection and processing statistics are shown in Table 2.
|
2.4. Structure-solution and statistics
Human Spt16 NTD crystals belonged to F432 with one molecule in the Initial phases were obtained by with Phaser (Storoni et al., 2004) using S. cerevisiae Spt16 NTD (PDB entry 3biq ; 32% sequence identity to human Spt16 NTD; VanDemark et al., 2008) as the initial search model. The model was built in Coot (Emsley & Cowtan, 2004) and refined using PHENIX (Adams et al., 2010). The structure of human Spt16 NTD was refined to 1.84 Å resolution. The model contains only chain A (residues 2–432). Residues 433–510 were absent from the electron density. Side chains with poor electron density were built as stubbed residues. Details of the are shown in Table 3.
|
2.5. Isothermal titration calorimetry
Binding interactions between human Spt16 NTD and histones H2A/H2B, H3/H4 or the N-terminal tails of H3 or H4 were analysed by ITC using an iTC200 (MicroCal, GE Life Sciences). Experiments were conducted at 298 K with buffer consisting of 20 mM HEPES–NaOH pH 7.5, 150 mM NaCl, 1 mM TCEP. Histone H2A/H2B or H3/H4 was loaded into the cell at a concentration of 30–40 µM. Human Spt16 NTD was loaded into the injection syringe at a concentration ten times higher than that of the histones in the cell. For interactions of Spt16 NTD with H3 or H4 N-terminal human Spt16 NTD was loaded into the cell at a concentration of 50 µM while histone H3 or H4 were loaded into the syringe at a concentration 10–20 times higher than that of Spt16 NTD in the cell. 20 injections (2 µl each) were added every 180 s to the cell. For control experiments, buffer was injected into the cell containing the protein. ITC data were generated by subtracting the raw data from the control experiment and were then analyzed using the Origin software (v.7). The histone N-terminal sequences are MARTKQTARKSTGGKAPRKQLATKAARKSAPSTGGVKK for H3 (Abgent) and MSGRGKGGKGLGKGGAKRHRKVLRDN for H4 (Abgent). were weighed and dissolved in Milli-Q water at 50 mM and then diluted into the appropriate buffer.
3. Results and discussion
3.1. of human Spt16 NTD
Our human Spt16 NTD construct consists of residues 1–510. The purified protein gave a band at between 49 and 62 kDa (Fig. 1a), which agrees with the calculated molecular weight of 57.9 kDa. The protein crystallized at 292 K after 1 d (Fig. 1b) and these crystals diffracted to a resolution of 1.84 Å with F432 and one molecule of Spt16 NTD per While the construct contains residues 1–510, electron density for residues 433–510 was not visible. The structure of human Spt16 NTD reveals two lobes: an N-lobe comprising residues 1–175 and a C-lobe comprising residues 176–432. Although human Spt16 NTD shares only 32 and 35% sequence identity with the structurally characterized S. cerevisiae and S. pombe Spt16 NTDs, respectively, it adopts a similar aminopeptidase-like fold in which the C-lobe resembles a pita-bread fold (Figs. 2a and 2b; Stuwe et al., 2008; VanDemark et al., 2008). Superimposition of the human Spt16 NTD structure onto the structures of Spt16 NTD from S. cerevisiae (r.m.s.d. of 1.22 Å for all Cα atoms) and S. pombe (r.m.s.d. of 0.86 Å for all Cα atoms) shows slight differences in the loop regions in the N- and C-lobes owing to variations in the amino-acid sequences and lengths (Figs. 2c and 2d). Despite the presence of a linker between the two lobes, the orientation of the two lobes appears to be rigid across the three Spt16 NTD structures.
3.2. Human Spt16 NTD binds histone H3/H4 with micromolar affinity
Earlier studies on S. pombe Spt16 NTD show that it forms a 1:1 complex with the H3/H4 dimer but that it does not bind the H2A/H2B dimer in pull-down experiments. Moreover, it binds histone H3 and H4 N-terminal tails with low-micromolar affinity (Stuwe et al., 2008). A pocket harbouring Ser83 and Lys86 in S. pombe Spt16 NTD was shown to be involved in binding the H4 N-terminal tail. These residues are conserved in both human and S. cerevisiae Spt16 NTD and they adopt a similar configuration in all three structures (Fig. 3). This prompted us to investigate whether human Spt16 NTD has a role in binding histones and histone N-terminal tails.
To assess whether human Spt16 NTD binds the histone H3 and H4 N-terminal tails, we performed ITC experiments to measure the binding affinity between human Spt16 NTD and the H3 or H4 N-terminal a and 4b), suggesting that human Spt16 NTD does not bind histone H3 or H4 N-terminal tails or that the interaction is too weak to be detected at the concentrations used in our assays. It is noteworthy that our assay was performed at 150 mM NaCl concentration, while in the studies of S. pombe Spt16 NTD 25 mM NaCl was used. Stuwe and coworkers have shown that the salt concentration influences the interaction of Spt16 NTD with histone tails in vitro (Stuwe et al., 2008). Unfortunately, human Spt16 NTD precipitated heavily and rapidly at 25 mM NaCl, thus preventing further analysis. It is likely that these interactions depend on the used in the in vitro binding assays and this may differ between species. Another possible explanation that may account for the differences in histone-tail binding abilities across different species is that the human and S. pombe Spt16 NTD structures have different electrostatic surface potentials (Fig. 5). Consistent with this suggestion, no binding of histone N-terminal tails is observed with S. cerevisiae Spt16 NTD (VanDemark et al., 2008).
ITC experiments showed that there was no change when H3 or H4 peptide was added to human Spt16 NTD (Figs. 4To examine whether human Spt16 NTD binds histones, we performed ITC analyses of human Spt16 NTD against H2A/H2B or H3/H4. An ITC experiment with human Spt16 NTD against H2A/H2B showed very little change in Kd of 2.84 ± 0.61 µM; N = 0.88 ± 0.03; Figs. 4c and 4d). Together, these data show that human Spt16 NTD is likely to bind H3/H4 via the core histone.
when Spt16 NTD was added to H2A/H2B, suggesting that Spt16 NTD does not bind H2A/H2B or binds with a very weak affinity. On the other hand, human Spt16 NTD binds histones H3/H4 with low-micromolar affinity (3.3. A conserved pocket on Spt16 NTD might contribute to histone binding
To explore how human Spt16 NTD may interact with histones, we analysed the surface-residue conservation of Spt16 NTD to identify hypothetical patches that may be involved in histone binding. Sequence alignment of Spt16 NTD from various species was performed and the sequence conservation was mapped onto the structure of human Spt16 NTD (Fig. 6). The analysis revealed clusters of conserved residues on the C-lobe and in a pocket between the N-lobe and the C-lobe. Furthermore, electrostatic surface analysis of human Spt16 NTD showed an acidic patch that co-localizes within this conserved pocket (Fig. 5a, middle panel), suggesting a possible role of this region in histone interaction. The electrostatic maps also show acidic patches at the bottom of the C-lobe and at the top of the N-lobe that may be potential histone-binding sites (Figs. 5d and 5e). Further studies are required to elucidate how Spt16 NTD interacts with histones. Our data are consistent with previous studies suggesting that Spt16 NTD is likely to play a supportive role with other FACT domains in modulating nucleosome assembly.
4. Conclusion
Little is known about Spt16 NTD and its functions. Here, we have reported the S. cerevisiae and S. pombe Spt16 NTDs. Our ITC analyses showed that human Spt16 NTD is likely to bind histones H3/H4 through the histone core. Analysis of Spt16 NTD sequences from various species and the electrostatic surface of this domain reveal the presence of a conserved acidic pocket that may be involved in histone binding (Fig. 5a, middle panel, and Fig. 6b). Interestingly, some Spt16 NTD mutations that are lethal in conjunction with SSRP1 mutations cluster in a region near this conserved pocket (VanDemark et al., 2008). Further studies will be required in order to elucidate how FACT domains cooperate to bind histones.
of human Spt16 NTD and shown that it adopts a structure similar to those ofAcknowledgements
We thank Gary Sibbet for helping us during histone purification and DLS for access to beamline I02 (mx8659), which contributed to the results presented here. This work was funded by Cancer Research UK. DTH was funded by ERC grant No. 647849.
References
Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221. Web of Science CrossRef CAS IUCr Journals Google Scholar
Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. (2001). Proc. Natl Acad. Sci. USA, 98, 10037–10041. Web of Science CrossRef PubMed CAS Google Scholar
Belotserkovskaya, R., Oh, S., Bondarenko, V. A., Orphanides, G., Studitsky, V. M. & Reinberg, D. (2003). Science, 301, 1090–1093. CrossRef PubMed CAS Google Scholar
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Formosa, T., Eriksson, P., Wittmeyer, J., Ginn, J., Yu, Y. & Stillman, D. J. (2001). EMBO J. 20, 3506–3517. CrossRef PubMed CAS Google Scholar
Gurard-Levin, Z. A., Quivy, J.-P. & Almouzni, G. (2014). Annu. Rev. Biochem. 83, 487–517. CAS PubMed Google Scholar
Hainer, S. J., Charsar, B. A., Cohen, S. B. & Martens, J. A. (2012). G3, 2, 555–567. Google Scholar
Heo, K., Kim, H., Choi, S. H., Choi, J., Kim, K., Gu, J., Lieber, M. R., Yang, A. S. & An, W. (2008). Mol. Cell, 30, 86–97. CrossRef PubMed CAS Google Scholar
Hondele, M., Stuwe, T., Hassler, M., Halbach, F., Bowman, A., Zhang, E. T., Nijmeijer, B., Kotthoff, C., Rybin, V., Amlacher, S., Hurt, E. & Ladurner, A. G. (2013). Nature (London), 499, 111–114. CrossRef CAS PubMed Google Scholar
Kabsch, W. (2010). Acta Cryst. D66, 125–132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kasai, N., Tsunaka, Y., Ohki, I., Hirose, S., Morikawa, K. & Tate, S. (2005). J. Biomol. NMR, 32, 83–88. CrossRef PubMed CAS Google Scholar
Kemble, D. J., McCullough, L. L., Whitby, F. G., Formosa, T. & Hill, C. P. (2015). Mol. Cell, 60, 294–306. CrossRef CAS PubMed Google Scholar
Kemble, D. J., Whitby, F. G., Robinson, H., McCullough, L. L., Formosa, T. & Hill, C. P. (2013). J. Biol. Chem. 288, 10188–10194. CrossRef CAS PubMed Google Scholar
Lambert, S. J., Nicholson, J. M., Chantalat, L., Reid, A. J., Donovan, M. J. & Baldwin, J. P. (1999). Acta Cryst. D55, 1048–1051. Web of Science CrossRef CAS IUCr Journals Google Scholar
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. (1997). Nature (London), 389, 251–260. CAS PubMed Web of Science Google Scholar
Masse, J. E., Wong, B., Yen, Y.-M., Allain, F. H.-T., Johnson, R. C. & Feigon, J. (2002). J. Mol. Biol. 323, 263–284. Web of Science CrossRef PubMed CAS Google Scholar
McCullough, L., Rawlins, R., Olsen, A., Xin, H., Stillman, D. J. & Formosa, T. (2011). Genetics, 188, 835–846. CrossRef CAS PubMed Google Scholar
Myers, C. N., Berner, G. B., Holthoff, J. H., Martinez-Fonts, K., Harper, J. A., Alford, S., Taylor, M. N. & Duina, A. A. (2011). PLoS One, 6, e20847. CrossRef PubMed Google Scholar
O'Donnell, A. F., Brewster, N. K., Kurniawan, J., Minard, L. V., Johnston, G. C. & Singer, R. A. (2004). Nucleic Acids Res. 32, 5894–5906. PubMed CAS Google Scholar
Orphanides, G., LeRoy, G., Chang, C.-H., Luse, D. S. & Reinberg, D. (1998). Cell, 92, 105–116. CrossRef CAS PubMed Google Scholar
Orphanides, G., Wu, W.-H., Lane, W. S., Hampsey, M. & Reinberg, D. (1999). Nature (London), 400, 284–288. PubMed CAS Google Scholar
Storoni, L. C., McCoy, A. J. & Read, R. J. (2004). Acta Cryst. D60, 432–438. Web of Science CrossRef CAS IUCr Journals Google Scholar
Stuwe, T., Hothorn, M., Lejeune, E., Rybin, V., Bortfeld, M., Scheffzek, K. & Ladurner, A. G. (2008). Proc. Natl Acad. Sci. USA, 105, 8884–8889. CrossRef PubMed CAS Google Scholar
VanDemark, A. P., Blanksma, M., Ferris, E., Heroux, A., Hill, C. P. & Formosa, T. (2006). Mol. Cell, 22, 363–374. CrossRef PubMed CAS Google Scholar
VanDemark, A. P., Xin, H., McCullough, L., Rawlins, R., Bentley, S., Heroux, A., Stillman, D. J., Hill, C. P. & Formosa, T. (2008). J. Biol. Chem. 283, 5058–5068. CrossRef PubMed CAS Google Scholar
Winkler, D. D., Muthurajan, U. M., Hieb, A. R. & Luger, K. (2011). J. Biol. Chem. 286, 41883–41892. CrossRef CAS PubMed Google Scholar
Winter, G. (2010). J. Appl. Cryst. 43, 186–190. Web of Science CrossRef CAS IUCr Journals Google Scholar
Xin, H., Takahata, S., Blanksma, M., McCullough, L., Stillman, D. J. & Formosa, T. (2009). Mol. Cell, 35, 365–376. CrossRef PubMed CAS Google Scholar
Zunder, R. M., Antczak, A. J., Berger, J. M. & Rine, J. (2012). Proc. Natl Acad. Sci. USA, 109, E144–E153. CrossRef CAS PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.